Catalyst Wire Dossier Catalyst Wire Dossier

Subcutaneous rapid-acting insulin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subcutaneous rapid-acting insulin, covering 2014-10-16 to 2014-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes [Phase 2]

See pricing